APA ציטוט

Moujalled, D. M., Pomilio, G., Ghiurau, C., Ivey, A., Salmon, J., Rijal, S., . . . Wei, A. H. (2018). Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia. Leukemia.

Citação norma Chicago

Moujalled, Donia M., et al. "Combining BH3-mimetics to Target Both BCL-2 and MCL1 Has Potent Activity in Pre-clinical Models of Acute Myeloid Leukemia." Leukemia 2018.

ציטוט MLA

Moujalled, Donia M., et al. "Combining BH3-mimetics to Target Both BCL-2 and MCL1 Has Potent Activity in Pre-clinical Models of Acute Myeloid Leukemia." Leukemia 2018.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.